
Indivior
A global pharmaceutical company working to help change patients’ lives by pioneering life-transforming treatment for addiction and other serious mental illnesses.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 | round | |
* | N/A | Post IPO Equity | |
Total Funding | 000k |
USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 22 % | 14 % | 21 % | 9 % | (9 %) | (1 %) | 6 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 26 % | (6 %) | 6 % | 24 % | 30 % | 32 % | 33 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 26 % | (6 %) | - | - | 15 % | 19 % | 19 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 7 % | 8 % | 10 % | 9 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Indivior is a global pharmaceutical company dedicated to developing medicines that treat substance use disorders and serious mental illnesses. The company operates in the healthcare sector, focusing on patients who suffer from addiction and mental health issues. Indivior's business model revolves around research and development of innovative treatments, which are then brought to market to improve patient outcomes. The company generates revenue through the sale of its pharmaceutical products, which are prescribed by healthcare professionals and used by patients worldwide. Indivior's commitment to patient safety and high-quality treatments is evident in its rigorous monitoring and reporting systems for product concerns and adverse events. By addressing critical healthcare needs, Indivior aims to create sustainable value and make a significant impact on global health.
Keywords: pharmaceutical, addiction treatment, mental health, substance use disorders, patient safety, innovative medicines, global healthcare, research and development, sustainable value, healthcare professionals.
Tech stack
Investments by Indivior
Edit
